Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. (Q46813416)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. |
scientific article |
Statements
1 reference
Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. (English)
1 reference
1 reference
Everett E Vokes
1 reference
Daniel A Haber
1 reference
Mark W Lingen
1 reference
Leslie E Martin
1 reference
Patricia L Harris
1 reference
Brian W Brannigan
1 reference
Sara M Haserlat
1 reference
Ross A Okimoto
1 reference
Dennis C Sgroi
1 reference
Sonika Dahiya
1 reference
Beth Muir
1 reference
John R Clark
1 reference
James W Rocco
1 reference
Daphne W Bell
1 reference
1 November 2005
1 reference
11
1 reference
22
1 reference
8105-8108
1 reference
Identifiers
1 reference